In Vitro Diagnostic (IVD) Trends and Market Update: December 2024

    Published: December 6, 2024 | Price: $5,000.00 – $10,500.00

    The in vitro diagnostics (IVD) market has demonstrated robust growth, driven by technological advancements and expanding opportunities. Diagnostic testing has evolved from merely diagnosing illnesses to providing critical insights for precision medicine treatments. Although COVID-19 testing has declined, it continues to contribute to overall revenues in 2024. The market remains dynamic, influenced by new product developments, shifts in global health spending, regulatory changes, and disease trends, maintaining its resilience. Several segments within the IVD market are experiencing significant growth and...
    In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029

    Published: November 25, 2024 | Price: $5,000.00 – $10,500.00

    The U.S. IVD market is a cornerstone of global healthcare innovation—but it is also a market in transition In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029, the fifth edition in Kalorama’s ongoing series, offers unparalleled access to insights on the trends and technologies that will define the industry's future. This report is essential for: Identifying market gaps and opportunities for product innovation. Gaining a competitive edge with strategic insights into the U.S. diagnostic landscape. Making informed...
    Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028

    Published: November 29, 2023 | Price: $5,000.00 – $10,000.00

    In recent decades, the introduction of various new genetic technologies for research use and diagnostics has revolutionized many areas and opened new frontiers in healthcare.  For example, next-generation sequencing (NGS) technologies have become widely used in genetic diseases, and have grown rapidly in oncology, due to the comprehensive insights they can provide at a relatively low cost.  While older, PCR continues to be innovated and remains a central tool in molecular diagnostics laboratories of all kinds, and in situ hybridization...
    In Vitro Diagnostic (IVD) Trends and Market Update: November 2023

    Published: November 7, 2023 | Price: $3,750.00 – $7,500.00

    In vitro diagnostic (IVD) testing is getting back to regular business and continues to be a driving force in the practice of medicine. It has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. COVID-19 testing continues to decline but is still a factor in total revenues for 2023. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors...
    The U.S. Market for Direct-to-Consumer (DTC) Laboratory Testing

    Published: May 26, 2022 | Price: $5,000.00 – $10,000.00

    Direct to consumer laboratory testing is also known as patient-ordered laboratory testing. A variety of tests are now available for direct to consumer testing. The growing market for direct-to-consumer laboratory testing may promote awareness of health issues and genetic diseases, which will allow patients to take a more proactive role in their healthcare. With advances in technology, the completion of the sequencing of the human genome and the pressures of the pandemic, direct to consumer lab testing is becoming increasingly...
    Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities

    Published: June 17, 2020 | Price: $6,000.00 – $12,000.00

    Kalorama Information's report provides a comprehensive market analysis and business planning tool for the market for tests that are aligned with a pharmaceutical treatment.  Especially in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that can dramatically improve outcomes.   Companion diagnostics can also decrease costs by identifying the patient population that will most likely benefit...